drugset / Trial / NCT03446209
Tocilizumab for the Treatment of Familial Mediterranean Fever
RandomizedParallel-groupDouble-blindTreatment
Summary
Adult patients with Familial Mediterranean Fever, who have active disease
Timeline
- Start
- 2018-04-23
- Primary completion
- 2020-10-30
- Completion
- 2020-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tocilizumab | Monoclonal antibody | — | Intravenous |